-
公开(公告)号:US20050277642A1
公开(公告)日:2005-12-15
申请号:US11198968
申请日:2005-08-08
IPC分类号: C07D251/52 , C07D251/54 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/14 , C07D521/00 , A61K31/53 , A61K31/506 , C07D43/14
CPC分类号: C07D231/12 , C07D233/56 , C07D249/08 , C07D251/52 , C07D251/54 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/14
摘要: Compounds that selectively inhibit inappropriate kinase activities and methods for their preparation are disclosed. In one embodiment, the compounds are represented by Formula I, As selective inhibitors of inappropriate kinase activities, the compounds of the present invention are useful in the treatment of conditions associated with such activity, including, but not limited to, inflammatory and autoimmune responses, diabetes, asthma, psoriasis, inflammatory bowel disease, transplantation rejection, and tumor metastasis. Also disclosed are methods of inhibiting inappropriate kinase activities and methods of treating conditions associated with such activities.
摘要翻译: 公开了选择性抑制不适当激酶活性的化合物及其制备方法。 在一个实施方案中,化合物由式I代替,作为不适当激酶活性的选择性抑制剂,本发明的化合物可用于治疗与此类活性相关的病症,包括但不限于炎性和自身免疫应答, 糖尿病,哮喘,牛皮癣,炎症性肠病,移植排斥反应和肿瘤转移。 还公开了抑制不适当的激酶活性的方法和治疗与这些活性相关的病症的方法。
-
公开(公告)号:US20050239770A1
公开(公告)日:2005-10-27
申请号:US11143430
申请日:2005-06-02
申请人: Kevin Moriarty , Yvonne Shimshock , Gulzar Ahmed , Junjun Wu , James Wen , Wei Li , Shawn Erickson , Jeffrey Letourneau , Edward McDonald , Katerina Leftheris , Stephen Wrobleski , Zahid Hussain , Ian Henderson , Axel Metzger , John Baldwin , Alaric Dyckman
发明人: Kevin Moriarty , Yvonne Shimshock , Gulzar Ahmed , Junjun Wu , James Wen , Wei Li , Shawn Erickson , Jeffrey Letourneau , Edward McDonald , Katerina Leftheris , Stephen Wrobleski , Zahid Hussain , Ian Henderson , Axel Metzger , John Baldwin , Alaric Dyckman
IPC分类号: A61K31/40 , A61K31/551 , C07D251/52 , C07D251/54 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/14 , C07D521/00
CPC分类号: C07D251/52 , C07D231/12 , C07D233/56 , C07D249/08 , C07D251/48 , C07D251/54 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14
摘要: N-heterocyclic compounds that block cytokine production via inhibition of p38 kinase are disclosed. In one embodiment, compounds of the present invention are represented by Formula I: Methods of production, pharmaceutical compositions and methods of treating conditions associated with inappropriate p38 kinase activity or TNF-α expression utilizing compounds of the present invention are also disclosed.
摘要翻译: 公开了通过抑制p38激酶阻断细胞因子产生的N-杂环化合物。 在一个实施方案中,本发明的化合物由式I表示:还公开了使用本发明化合物的生产方法,药物组合物和治疗与不适当的p38激酶活性或TNF-α表达相关的病症的方法。
-
公开(公告)号:US20070078165A1
公开(公告)日:2007-04-05
申请号:US11526523
申请日:2006-09-25
申请人: Steven Berthel , Shawn Erickson , Nader Fotouhi , Robert Kester , Kyungjin Kim , Steven Mischke , Yimin Qian , Kshitij Thakkar , Jefferson Tilley , Hong Wang
发明人: Steven Berthel , Shawn Erickson , Nader Fotouhi , Robert Kester , Kyungjin Kim , Steven Mischke , Yimin Qian , Kshitij Thakkar , Jefferson Tilley , Hong Wang
IPC分类号: A61K31/454 , C07D403/02
CPC分类号: C07D401/04 , C07D401/14 , C07D471/04
摘要: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of obesity, hyperphagia, anxiety, depression and related disorders and diseases.
摘要翻译: 本文提供式(I)的化合物及其药学上可接受的盐,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗肥胖,食欲过盛,焦虑,抑郁和相关疾病和疾病。
-
公开(公告)号:US20080115073A1
公开(公告)日:2008-05-15
申请号:US11871032
申请日:2007-10-11
申请人: Shawn Erickson , Bradley Kohn , Andrew Duncan
发明人: Shawn Erickson , Bradley Kohn , Andrew Duncan
IPC分类号: G06F3/048
CPC分类号: G06F3/1454 , G06F3/038 , G06F3/04812 , G06F3/1462 , G06F2203/0383 , G06F2203/04804 , G09G5/14 , H04L67/38
摘要: Method and system for the remote display of drawn content. In one embodiment, a drawing window is created at a source device, a location of a system mouse event is observed at a viewer device and the transparency of a pixel in the drawing window at the source device at the location of the mouse event is manipulated. The pixel may be cleared, thereby making the location of the mouse event transparent, which may send the mouse event to a non-transparent window immediately below the drawing window.
摘要翻译: 用于远程显示绘制内容的方法和系统。 在一个实施例中,在源设备处创建绘图窗口,在观察器设备处观察系统鼠标事件的位置,并且处理在鼠标事件的位置处的源设备处的绘图窗口中的像素的透明度 。 可以清除像素,从而使鼠标事件的位置是透明的,这可以将鼠标事件发送到绘图窗口正下方的不透明窗口。
-
-
-